← Leaderboards
Yvette L. Kasamon
Johns Hopkins University
$706,089
Attributed
$706,089
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $140.9K · FY2007–12$200K$150K$100K$50K$0
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$706,089 · 2
By mechanism
K23$704,700 · 1
M01$1,389 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Tza-Huei Jeff Wang$29,391,444
- Richard F. Ambinder$9,273,650
- James G. Herman$8,069,882
- Michael G. Goggins$19,822,981
- S Diane Hayward$11,654,835
Others in their field
Top investigators on “Stem Cells”
- Mary M Horowitz · Medical College Of Wisconsin$220,248,453
- David Heimbrook · Leidos Biomedical Research, Inc.$161,931,307
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$73,044,559
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$70,591,644
- Michelle M Le Beau · University Of Chicago$70,506,423
Research focus
Stem CellsHodgkin DiseaseRelapseCancer VaccinesDoseCyclophosphamideLymphomaMonitorResponseVaccinesRituximabBaseImmunologicsReporterAffectImmunotherapyClinical ResearchAllogenicCellsImmunotherapeutic AgentInsightEvaluationEffectivenessCancer Stem Cell
Grant awards (6)
Novel Biologic Therapies for Hodgkin's Lymphoma$140,940
K23 · FY2012 · CA · contact PI
Novel Biologic Therapies for Hodgkin's Lymphoma$140,940
K23 · FY2011 · CA · contact PI
Novel Biologic Therapies for Hodgkin's Lymphoma$140,940
K23 · FY2010 · CA · contact PI
Novel Biologic Therapies for Hodgkin's Lymphoma$140,940
K23 · FY2009 · CA · contact PI
Novel Biologic Therapies for Hodgkin's Lymphoma$140,940
K23 · FY2008 · CA · contact PI
RITUXIMAB, HIGH DOSE CYCLOPHOSPHAMIDE, AND GM-CSF BASED IMMUNOTHERAPY$1,389
M01 · FY2007 · RR · contact PI